跳至主要内容
临床试验/CTRI/2023/12/060409
CTRI/2023/12/060409尚未招募2 期

Randomized open label, placebo controlled clinical trial to assess the efficacy of ajmodadi churna in the management of Katigatavata with special reference to lumbar spondylosis. - Nil

Siddhakala ayurved mahavidyalaya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient willing for clinical study having Age group 40-70 years.
  • 2. X ray lumbar spine (AP and lateral view) showing changes of
  • lumbar spondylosis
  • 3. Patients having signs and symptoms of Katigatvata mentioned in
  • 4. Irrespective of genders and caste and socioeconomic class.
  • 5. The Roland and Morris low back pain and disability questionnaire
  • score more than or equal to 5.
  • 6. Low back pain more than 3 months.

排除标准

  • 1. Patient not willing for study.
  • 2. Patient having fracture of lumbar vertebra, disc herniation etc.
  • 3. Patients suffering from Pelvic Inflammatory diseases.
  • 4. Patients suffering from any other chronic systemic disorders.
  • 5. Pregnant and lactating mother.
  • 6. Diagnosed case of Rheumatoid arthritis, Gout etc.

研究者

发起方
Siddhakala ayurved mahavidyalaya

相似试验